Profit Over Patients: How Financial Corporations Prioritize Earnings at the Expense of Patient Care

The U.S. healthcare system, despite its advanced technologies, faces critical issues with affordability, accessibility, and care quality. This study investigates the financial motivations behind these challenges, revealing how key players—nonprofit and for-profit hospitals, insurance companies, and lobbyists—often prioritize profits over patient well-being. Through an analysis of restrictive insurance policies, the influence of lobbying in legislative decisions, and the Purdue Pharma case’s impact on the opioid crisis, the research highlights the ways corporate profit strategies compromise patient access and safety. Findings underscore that lobbying efforts and insurance barriers significantly raise healthcare costs, reduce transparency, and limit patient access to essential care. The study calls for policy reforms focused on protecting patient welfare over corporate interests, exploring alternatives like universal healthcare or price control measures to curb exploitative practices. This paper emphasizes the need for a balanced healthcare model, prioritizing affordability, transparency, and patient-centered care over profit maximization.